



















Study with the several resources on Docsity
Earn points by helping other students or get them with a premium plan
Prepare for your exams
Study with the several resources on Docsity
Earn points to download
Earn points by helping other students or get them with a premium plan
Community
Ask the community for help and clear up your study doubts
Discover the best universities in your country according to Docsity users
Free resources
Download our free guides on studying techniques, anxiety management strategies, and thesis advice from Docsity tutors
NURS 5334 UTA Advanced Pharmacology (Pharmacology 5334) Module 2 exam with verified detailed answers
Typology: Exams
1 / 27
This page cannot be seen from the preview
Don't miss anything!
Treatment |! of |! choice |! for |! oral |! therapy |! of |! UTI's |! - |! Correct |! answer |! ✔TMP/SMZ |! for |! 3 |! days; |! Nitrofurantoin |! for |! 5 |! days Second |! line |! drugs |! for |! UTI |! - |! Correct |! answer |! ✔Ciprofloxacin |! and |! levofloxacin |! for |! 3 |! days Nitrofurantoin |! - |! Correct |! answer |! ✔Urinary |! tract |! antiseptic Nitrofurantoin |! uses |! - |! Correct |! answer |! ✔Lower |! UTI's; |! prophylaxis; |! recurrent |! lower |! UTI's. |! (not |! absorbed |! systemically: |! cannot |! be |! used |! for |! anything |! in |! the |! kidneys) Nitrofurantoin |! adverse |! effects |! - |! Correct |! answer |! ✔GI |! effects; |! pulmonary |! reactions; |! hematologic |! effects; |! peripheral |! neuropathy |! (demyelination |! and |! nerve |! degeneration |! can |! occur |! and |! may |! be |! irreversible); |! hepatotoxicity; |! birth |! defects Methenamine |! - |! Correct |! answer |! ✔Decomposes |! to |! formaldehyde |! and |! ammonia; |! used |! for |! chronic |! lower |! UTI's; |! contraindicated |! in |! renal |! and |! liver |!
failure; |! drug |! interactions |! - |! urinary |! alkalinizers, |! which |! reduce |! effects, |! sulfonamides |! pose |! risk |! for |! crystalluria Acute |! cystitis |! treatment |! - |! Correct |! answer |! ✔Single |! dose |! therapy: |! fosfomycin; |! short-course |! therapy: |! TMP/SMZ |! for |! 3 |! days; |! conventional |! therapy: |! nitrofurantoin |! for |! 7 |! days Acute |! uncomplicated |! pyelonephritis |! treatment |! - |! Correct |! answer |! ✔First |! line: |! TMP/SMZ, |! ciprofloxacin, |! and |! levofloxacin |! for |! 10-14 |! days; |! second |! line: |! augmentin, |! cephalexin Complicated |! UTI |! treatment |! - |! Correct |! answer |! ✔TMP/SMZ |! for |! 7-14 |! days, |! ciprofloxacin |! for |! 7-14 |! days, |! levofloxacin |! for |! 5-14 |! days, |! augmentin |! for |! 7-14 |! days, |! cephalexin |! for |! 7-14 |! days Recurrent |! UTI |! treatment |! - |! Correct |! answer |! ✔Prophylaxis |! with |! TMP/SMZ |! 3 |! times |! weekly |! for |! 6 |! months; |! TMP |! at |! bedtime |! for |! 6 |! months; |! OR |! nitrofurantoin |! at |! bedtime |! for |! 6 |! months Acute |! bacterial |! prostatitis |! treatment |! - |! Correct |! answer |! ✔-floxacins |! for |! 2-4 |! weeks Evaluation |! of |! drug |! sensitivity |! - |! Correct |! answer |! ✔Best |! done |! with |! sputum |! culture |! (takes |! up |! to |! 16 |! weeks |! for |! results); |! drugs |! are |! chosen |! by |! patterns |! of |! drug |! resistance |! in |! the |! community |! and |! immunocompetence |! of |! the |! patient; |! a |! new |! automated |! TB |! assay |! can |! identify |! sensitivity |! to |! rifampin |! in |! 2 |! hours |! and |! confirm |! the |! presence |! of |! M. |! tuberculosis
MDR-TB |! and |! XDR-TB |! treatment |! - |! Correct |! answer |! ✔ 24 |! months |! with |! 2nd |! and |! 3rd |! line |! drugs; |! poor |! prognosis Patients |! with |! TB |! plus |! HIV |! - |! Correct |! answer |! ✔More |! aggressive |! therapy |! required; |! minimum |! 6 |! months |! of |! treatment; |! rifampin |! accelerates |! metabolism |! of |! antiretroviral |! therapy |! drugs |! and |! decreases |! their |! effects Promoting |! drug |! adherence |! in |! TB |! patients |! - |! Correct |! answer |! ✔Directly |! Observed |! Therapy |! (DOT) |! - |! also |! allows |! for |! ongoing |! assessment |! of |! clinical |! signs; |! intermittent |! dosing: |! 2-3 |! times/week Latent |! TB |! tests |! - |! Correct |! answer |! ✔TB |! skin |! test; |! interferon |! Gamma |! Release |! Assays Latent |! TB |! treatment |! - |! Correct |! answer |! ✔Isoniazid |! alone |! for |! 9 |! months; |! isoniazid |! and |! rifampin |! weekly |! for |! 3 |! months; |! active |! TB |! must |! be |! ruled |! out TB |! vaccination |! - |! Correct |! answer |! ✔Bacillus |! Calmette |! and |! Guerin |! (BCG) |! vaccine Second |! line |! treatment |! of |! TB |! - |! Correct |! answer |! ✔Levofloxacin, |! moxifloxacin, |! kanamycin, |! amikacin, |! capreomycin, |! stretpomycin, |! para-aminosalicylic |! acid, |! ethonamid |! cycloserine
Isoniazid |! - |! Correct |! answer |! ✔Standard |! treatment |! for |! latent |! TB; |! must |! be |! given |! for |! at |! least |! 6 |! months, |! preferably |! 9 |! months; |! poses |! a |! risk |! for |! liver |! damage Isoniazid |! adverse |! effects |! - |! Correct |! answer |! ✔Peripheral |! neuropathy |! (give |! pyridoxine |! and |! vitamin |! B6); |! hepatotoxicity; |! optic |! neuritis; |! anemia Rifampin |! use |! - |! Correct |! answer |! ✔TB, |! leprosy, |! meningococcus |! carriers Rifampin |! adverse |! effects |! - |! Correct |! answer |! ✔Hepatotoxic/hepatitis; |! discoloration |! of |! body |! fluids |! (red/orange); |! GI |! disturbances Rifampin |! drug |! interactions |! - |! Correct |! answer |! ✔Induces |! P450; |! can |! hasten |! drug |! metabolism |! - |! oral |! contraceptives, |! warfarin, |! drugs |! for |! HIV |! infection Ethambutol |! - |! Correct |! answer |! ✔Active |! against |! mycobacteria, |! tubercle |! bacilli |! that |! are |! resistant |! to |! isoniazid |! and |! rifampin; |! adverse |! effect: |! optic |! neuritis Ethambutol |! use |! - |! Correct |! answer |! ✔Initial |! treatment |! of |! TB |! and |! treatment |! of |! patients |! who |! have |! received |! therapy |! previously; |! always |! part |! of |! the |! multi- drug |! regimen Mycobacterium |! avian |! complex |! infection |! - |! Correct |! answer |! ✔Colonization |! begins |! in |! the |! lungs |! or |! GI |! tract; |! may |! spread |! to |! blood, |! bone |! marrow, |! liver, |! spleen, |! lymph |! nodes, |! brain, |! kidneys, |! and |! skin
Initial |! episode |! of |! herpes |! genitalis |! treatment |! - |! Correct |! answer |! ✔Acyclovir |! 400 |! mg |! 3 |! times |! daily |! for |! 7-10 |! days; |! Valacyclovir |! 1 |! gram |! 2 |! times |! daily |! for |! 10 |! days Episodic |! recurrences |! of |! herpes |! genitalis |! treatment |! - |! Correct |! answer |! ✔Acyclovir |! 400 |! mg |! 3 |! times |! daily |! for |! 5 |! days; |! Valacyclovir |! 500 |! mg |! 2 |! times |! daily |! for |! 3 |! days Long-term |! suppressive |! therapy |! of |! recurrent |! genital |! infections |! - |! Correct |! answer |! ✔Acyclovir |! 400 |! mg |! 2 |! times |! daily |! for |! up |! to |! 12 |! months; |! Valacyclovir |! 500-1000 |! mg |! every |! day |! for |! immunocompetent |! patients, |! and |! 500 |! mg |! twice |! daily |! for |! patients |! with |! HIV Acute |! therapy |! of |! herpes |! zoster |! - |! Correct |! answer |! ✔Acyclovir |! 800 |! mg |! 5 |! times |! daily |! for |! 7-10 |! days VZV |! (chickenpox) |! treatment |! - |! Correct |! answer |! ✔Acyclovir |! 20 |! mg/kg |! (no |! more |! than |! 800 |! mg) |! 4 |! times |! daily |! for |! 6 |! days; |! treatment |! should |! begin |! at |! earliest |! sign |! of |! rash; |! topical |! therapy: |! 5% |! cream |! applied |! 5 |! times |! daily; |! Valacyclovir |! (ages |! 2-18) |! 20 |! mg/kg |! (max |! 1 |! gram) |! three |! times |! daily Valacyclovir |! - |! Correct |! answer |! ✔Prodrug |! of |! acyclovir; |! uses: |! herpes |! zoster |! (shingles), |! herpes |! simplex |! genitalis, |! herpes |! labialis |! (cold |! sores), |! varicella |! (chicken |! pox) Valacyclovir |! absorption |! - |! Correct |! answer |! ✔Rapid |! absorption |! and |! essentially |! complete |! conversion |! to |! acyclovir
Herpes |! labialis |! treatment |! - |! Correct |! answer |! ✔Valacyclovir |! 2 |! g/dose |! 12 |! hours |! apart |! for |! 1 |! day Famcyclovir |! - |! Correct |! answer |! ✔Prodrug |! used |! to |! treat |! acute |! herpes |! zoster |! or |! genital |! herpes Famcyclovir |! absorption |! - |! Correct |! answer |! ✔Rapid |! from |! the |! GI |! tract; |! food |! decreases |! the |! rate |! of |! absorption |! but |! not |! the |! extent Famcyclovir |! metabolism |! - |! Correct |! answer |! ✔Enzymatic |! conversion |! to |! its |! active |! form Famcyclovir |! excretion |! - |! Correct |! answer |! ✔Renal, |! largely |! unchanged; |! plasma |! half |! life |! of |! 2.5 |! hours; |! half |! life |! in |! the |! cell |! is |! much |! longer Topical |! drugs |! for |! herpes |! - |! Correct |! answer |! ✔Penciclovir |! for |! recurrent |! herpes |! labialis; |! Docosonal |! OTC |! 10% |! cream Occular |! herpes |! infections |! treatment |! - |! Correct |! answer |! ✔Triflurdine, |! Ganciclovir |! 0.15% |! ophthalmic |! gel Cytomegalovirus |! (CMV) |! - |! Correct |! answer |! ✔Herpesvirus |! group; |! transmitted |! by |! direct |! contact |! with |! body |! fluids
Cidofovir |! kinetcs |! - |! Correct |! answer |! ✔IV |! infusion; |! excreted |! by |! the |! kidneys; |! probenecid |! competes |! for |! renal |! tubular |! secretion |! and |! delays |! elimination; |! prolonged |! intracellular |! half |! life |! (17-65 |! hours) |! and |! can |! have |! 2 |! weeks |! between |! doses Cidofovir |! adverse |! effects |! - |! Correct |! answer |! ✔BBW: |! nephrotoxicity; |! neutropenia; |! ocular |! disorders Foscarnet |! uses |! - |! Correct |! answer |! ✔Active |! against |! all |! known |! herpes |! viruses; |! less |! tolerated, |! more |! difficult |! to |! give Foscarnet |! adverse |! effects |! - |! Correct |! answer |! ✔BBW: |! nephrotoxicity; |! electrolyte/mineral |! imbalances Foscarnet |! absorption |! - |! Correct |! answer |! ✔Low |! oral |! bioavailability |! and |! must |! be |! given |! IV Foscarnet |! distribution |! - |! Correct |! answer |! ✔Poorly |! soluble |! in |! water |! and |! does |! not |! penetrate |! cells |! easily; |! give |! in |! large |! doses |! with |! large |! volumes |! of |! fluid Foscarnet |! excretion |! - |! Correct |! answer |! ✔10% |! to |! 20% |! of |! each |! dose |! is |! deposited |! in |! bone, |! the |! remainder |! is |! excreted |! in |! urine |! (reduce |! dose |! in |! renal |! impairment); |! half-life |! is |! 3-5 |! hours
Four |! classes |! of |! antifungal |! drugs |! - |! Correct |! answer |! ✔Polyene |! antibiotics, |! azoles, |! echinocandins, |! pyrimidine |! analogs Opportunistic |! fungal |! infections |! - |! Correct |! answer |! ✔-Candidiasis, |! aspergillosis, |! cryptococcosis, |! and |! mucormycosis -Usually |! occur |! in |! immunocompromised |! or |! debilitated |! population |! taking |! antibiotics, |! corticosteroids, |! chemotherapy, |! or |! other |! immunosuppressives Nonopportunistic |! fungal |! infections |! - |! Correct |! answer |! ✔Sporotrichosis, |! blastomycosis, |! histoplasmosis, |! coccidioidomycosis Amphotericin |! B |! BBW |! - |! Correct |! answer |! ✔Highly |! toxic. |! Only |! to |! be |! used |! in |! the |! setting |! of |! life |! threatening |! infections |! (infusion |! reaction |! and |! renal |! damage |! occur |! in |! many |! patients) Amphotericin |! B |! uses |! - |! Correct |! answer |! ✔Drug |! of |! choice |! for |! most |! systemic |! mycoses. |! Before |! its |! use, |! systemic |! fungal |! infections |! were |! usually |! fatal. |! Must |! be |! given |! IV Amphotericin |! B |! MOA |! - |! Correct |! answer |! ✔Binds |! ergosterol |! (unique |! to |! fungi); |! forms |! membrane |! pores |! that |! allow |! leakage |! of |! electrolytes. |! "Tears" |! holes |! in |! the |! fungal |! membrane |! by |! forming |! pores Amphotericin |! B |! adverse |! effects |! - |! Correct |! answer |! ✔Infusion |! reactions, |! nephrotoxicity, |! hypokalemia
Voriconazole |! uses/MOA |! - |! Correct |! answer |! ✔Candidemia, |! invasive |! aspergillosis |! (drug |! of |! choice), |! esophageal |! candidiasis, |! scedosporium |! apiospenum-resistant |! infections, |! suppresses |! synthesis |! of |! ergosterol Voriconazole |! adverse |! effects |! - |! Correct |! answer |! ✔Hepatotoxicity, |! visual |! disturbances, |! hallucinations, |! teratogenicity, |! hypersensitivity |! reactions, |! nausea, |! vomiting, |! abdominal |! pain, |! headache Voriconazole |! drug |! interactions |! - |! Correct |! answer |! ✔Metabolized |! by |! the |! P |! isoenzymes |! and |! inhibits |! P450 |! enzymes |! and |! can |! raise |! levels |! of |! other |! drugs Ketoconazole |! MOA/uses |! - |! Correct |! answer |! ✔Inhibits |! ergosterol; |! alternative |! to |! ampho |! B |! for |! systemic |! mycoses |! (slower |! effects); |! more |! useful |! in |! suppressing |! chronic |! infections |! than |! in |! treating |! severe |! acute |! infections Ketoconazole |! adverse |! effects |! - |! Correct |! answer |! ✔GI |! (can |! be |! reduced |! if |! given |! with |! food); |! hepatotoxicity |! (rare, |! but |! potentially |! fatal |! hepatic |! necrosis); |! BBW: |! should |! only |! be |! given |! for |! systemic |! infections |! because |! of |! fatal |! hepatic |! necrosis |! AND |! for |! use |! with |! drugs |! prolonging |! QT; |! can |! inhibit |! steroid |! synthesis |! in |! humans; |! rash, |! itching, |! dizziness, |! fever, |! chills, |! constipation, |! diarrhea, |! photophobia, |! and |! headache Prosaconazole |! adverse |! effects |! - |! Correct |! answer |! ✔Nausea, |! vomiting, |! liver |! damage, |! prolonged |! QT Prosaconazole |! drug |! interactions |! - |! Correct |! answer |! ✔Strong |! CYP3A4 |! inhibitor
Echinocandins |! - |! Correct |! answer |! ✔Newest |! class |! of |! antifungals; |! disrupts |! the |! fungal |! cell |! wall; |! given |! IV; |! used |! for |! aspergillus |! and |! candida |! infections Echinocandins |! adverse |! effects |! - |! Correct |! answer |! ✔Fever |! and |! phlebitis |! at |! injection |! site Echinocandins |! drug |! interactions |! - |! Correct |! answer |! ✔Drugs |! that |! induce |! CYP450 |! will |! decrease |! levels |! of |! this |! drug Flucytosine |! uses |! - |! Correct |! answer |! ✔Serious |! infection |! with |! susceptible |! strains |! of |! candida |! and |! cryptococcus |! neoformans |! (resistance |! common); |! often |! used |! with |! ampho |! B Flucytosine |! adverse |! effects |! - |! Correct |! answer |! ✔Bone |! marrow |! suppression, |! inhibits |! hepatic |! drug-metabolizing |! enzymes Flucytosine |! BBW |! - |! Correct |! answer |! ✔Should |! not |! be |! used |! in |! patients |! with |! renal |! impairment Superficial |! mycoses |! organisms |! - |! Correct |! answer |! ✔Candida |! species; |! dermatophytes |! (species |! of |! Epidermophyton, |! Tricophyton, |! and |! Microsporum) Vulvovaginal |! candidiasis |! treatment |! - |! Correct |! answer |! ✔1-3 |! days |! of |! topical |! therapy |! miconazole; |! single |! dose |! fluconazole
Oxiconazole |! and |! sulconazole |! - |! Correct |! answer |! ✔Topical |! treatment |! of |! tinea |! infections |! (ringworm) Griseofulvin |! uses |! - |! Correct |! answer |! ✔Superficial |! mycoses; |! ineffective |! systemic |! mycoses Griseofulvin |! adverse |! effects |! - |! Correct |! answer |! ✔Transient |! headache, |! rash, |! GI |! effects, |! insomnia, |! tiredness Nystatin |! - |! Correct |! answer |! ✔Polyene |! antifungal |! used |! only |! for |! candidiasis; |! drug |! of |! choice |! for |! intestinal |! candidiasis, |! also |! used |! for |! candida |! infections |! in |! skin, |! mouth, |! esophagus, |! and |! vagina Terbinafine |! - |! Correct |! answer |! ✔An |! allylamine |! used |! for |! topical |! ringworm, |! oral |! fungus, |! nail |! fungus Butenafine |! - |! Correct |! answer |! ✔Oral |! allylamine |! used |! for |! tinea |! pedis, |! corporis, |! cruris, |! and |! versicolor Chlamydia |! trachomatis |! infection |! - |! Correct |! answer |! ✔Most |! common |! bacterial |! STD |! in |! the |! US; |! can |! cause |! - |! genital |! tract |! infections, |! proctitis, |! conjunctivitis, |! lymphogranuloma |! verenuem, |! ophthalmia |! and |! pneumonia |! in |! infant, |! pelvic |! inflammatory |! disease |! if |! untreated |! in |! women
Chlamydia |! treatment |! (uncomplicated |! infections) |! - |! Correct |! answer |! ✔Azithromycin, |! doxycycline Chlamydia |! treatment |! (infants) |! - |! Correct |! answer |! ✔Erythromycin Chlamydia |! treatment |! (preadolescent |! children) |! - |! Correct |! answer |! ✔Erythromycin |! for |! child |! < |! 45 |! kg; |! azithromycin |! for |! children |! > |! 45 |! kg |! and |! under |! 8 |! y/o; |! azithromycin |! or |! doxycycline |! for |! children |! > |! 8 |! y/o Chlamydia |! treatment |! (lymphogranuloma |! vereneum) |! - |! Correct |! answer |! ✔Doxycycline |! or |! erythromycin Gonococcal |! infections: |! organisms/causes |! - |! Correct |! answer |! ✔Neisseria |! gonorrhoeae |! (gram-negative |! diplococcus); |! causes |! - |! urethral, |! cervical, |! and |! rectal |! infections; |! pharyngeal |! infection; |! conjunctivitis |! (treatment |! in |! neonates |! is |! single |! dose |! ceftriaxone) Gonococcal |! infection |! treatment |! - |! Correct |! answer |! ✔Cephalosporins Nongonococcal |! urethritis |! treatment |! - |! Correct |! answer |! ✔Azithromycin, |! doxycycline Pelvic |! Inflammatory |! Disease |! causes |! - |! Correct |! answer |! ✔N. |! gonorrhoeae, |! C. |! trachomatis
Cestodes |! (tapeworm) |! treatment |! - |! Correct |! answer |! ✔Praziquantel Trematodes |! (fluke) |! treatment |! - |! Correct |! answer |! ✔Praziquantel, |! triclabendazole, |! albendazole Ascariasis |! (giant |! roundworm) |! treatment |! - |! Correct |! answer |! ✔Albendazole, |! Mebendazole, |! ivermectin Pinworm |! treatment |! - |! Correct |! answer |! ✔Albendazole, |! mebendazole Ancylostomiasis |! and |! necatoriasis |! (hookworm) |! treatment |! - |! Correct |! answer |! ✔Albendazole, |! mebendazole, |! pyrantel |! pamoate Trichuriasis |! (whipworm) |! treatment |! - |! Correct |! answer |! ✔Albendazole Strongyloidasis |! (tapeworm) |! treatment |! - |! Correct |! answer |! ✔Ivermectin Nematode |! infestation |! (extra-intestinal) |! treatment |! - |! Correct |! answer |! ✔Trichinosis |! (pork |! roundworm) |! - |! albendazole; |! wucheresis |! and |! brugiasis |! - |! diethylcarbamazine; |! onchocercias |! (river |! blindness) |! - |! praziquantel Cestode |! infestation |! treatment |! - |! Correct |! answer |! ✔Taenisis |! (beef |! and |! pork |! tapeworm) |! - |! praziquantel; |! diphyllobothriasis |! (fish |! tapeworm) |! - |! praziquantel
Trematode |! infestation |! treatment |! - |! Correct |! answer |! ✔Schistosomiasis |! (blood |! flukes) |! - |! praziquantel; |! fascioliasis |! (liver |! fluke) |! - |! praziquantel |! or |! albendazole; |! fasciolopsiasis |! (intestinal |! fluke) |! - |! praziquantel Drugs |! of |! choice |! for |! helminthiasis |! - |! Correct |! answer |! ✔Mebendazole, |! albendazole, |! praziquantel, |! pyrantel |! pamoate, |! diethylcarbamazine, |! ivermectin Cephalosporins |! that |! interact |! with |! alcohol |! - |! Correct |! answer |! ✔Cefotetan |! and |! cefazolin Cephalosporins |! that |! decrease |! interference |! with |! vitamin |! K |! metabolism |! - |! Correct |! answer |! ✔Cefotetan |! and |! ceftriaxone Medication |! which |! can |! cause |! break |! through |! seizures |! if |! given |! with |! valproate |!